Literature DB >> 9503033

Adrenal renin-angiotensin-aldosterone system in streptozotocin-diabetic rats.

T Nakayama1, Y Izumi, M Soma, K Kanmatsuse.   

Abstract

Previous studies have indicated that the local renin-angiotensin system (RAS) plays an important role in the regulation of aldosterone release. We focused this study on examining the dissociating changes in circulating RAS and adrenal RAS, and we produced a low plasma renin status in streptozotocin (STZ)-induced diabetic rats. Four and six weeks after treatment with STZ, the rats showed hyperglycemia, hyporeninemia, decrease in plasma angiotensin II (AII), and a slight, but non-significant increase in plasma aldosterone in the rats. The adrenal renin activity and aldosterone concentration were significantly increased in the group of rats six weeks after induction of diabetes compared to those in control rats. The group of rats four weeks after induction of diabetes showed an increase in adrenal aldosterone concentration and a slight, but non-significant increase in adrenal renin activity. Plasma ACTH, serum sodium, and potassium were unchanged in both treatment groups compared to the control. The present results indicate that hyperactivity or residual activity of adrenal RAS under hyporeninemia is associated with severe diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9503033     DOI: 10.1055/s-2007-978824

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  2 in total

1.  Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart.

Authors:  Y Shimoni; K Chen; T Emmett; G Kargacin
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

2.  The ACE-2 in COVID-19: Foe or Friend?

Authors:  Rinkoo Dalan; Stefan R Bornstein; Ali El-Armouche; Roman N Rodionov; Alexander Markov; Ben Wielockx; Felix Beuschlein; Bernhard O Boehm
Journal:  Horm Metab Res       Date:  2020-04-27       Impact factor: 2.936

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.